Table 2. Functional status outcomes for the cohort.
NYHA class | P-value | ||||
Class I (n) | Class II (n) | Class III (n) | Class IV (n) | 0.73* | |
Pre-SGLT2i therapy | 5 | 10 | 31 | 7 | |
On SGLT2i therapy | 5 | 13 | 25 | 9 |
NYHA class | P-value | ||||
Class I (n) | Class II (n) | Class III (n) | Class IV (n) | 0.73* | |
Pre-SGLT2i therapy | 5 | 10 | 31 | 7 | |
On SGLT2i therapy | 5 | 13 | 25 | 9 |